Although potential for suicidality has been often cited as a reason to avoid VMAT2 inhibitors and these drug labels contain “black box” warnings of depressed mood and suicidal ideation, several studies found that tetrabenazine use was not associated with an increased incidence of depression or suicidality [22]. This evidence concerns the gene SLC18A2 and depressive disorder.